02 nov
|
Alexion, AstraZeneca Rare Disease
|
Barcelona
02 nov
Alexion, AstraZeneca Rare Disease
Barcelona
Lead integral market access, pricing, and reimbursement strategies for rare neurological diseases, focusing on NMOSD indication and lifecycle management to ensure patient access to transformative medicines.
📌 Global Pricing & Access Lead, Rare Neurology (Barcelona)
🏢 Alexion, AstraZeneca Rare Disease
📍 Barcelona